EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

Last updated 26 aprile 2024. Database contains 4917 unique substances/entries.

Filter the list

Mostrati 1.801 - 1.850 su 4.917 risultati.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU REACH: List of SVHC	EU_BA Directive 2000/54/EC
cobalt dimolybdenum nickel octaoxide	268-169-5	68016-03-5	Carc. 1A; STOT RE 1; Skin Sens. 1			Details
cobalt dinitrate	233-402-1	10141-05-6	Carc. 1B; Muta. 2; Repr. 1B; Resp. Sens. 1; Skin Sens. 1	C Carcinogenic (article 57a) R Toxic for reproduction (article 57c)		Details
cobalt lithium nickel oxide	442-750-5	113066-89-0	Carc. 1A; Acute Tox. 2; STOT RE 1; Skin Sens. 1			Details
cobalt nickel dioxide	261-346-8	58591-45-0	Carc. 1A; STOT RE 1; Skin Sens. 1			Details
cobalt nickel gray periclase; C.I. Pigment Black 25; C.I. 77332 This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77332.	269-051-6	68186-89-0	Carc. 1A; STOT RE 1; Skin Sens. 1			Details
cobalt nickel oxide	620-395-9	12737-30-3	Carc. 1A; STOT RE 1; Skin Sens. 1			Details
cobalt oxide	215-154-6	1307-96-6	Acute Tox. 4; Skin Sens. 1			Details
cobalt sulfate	233-334-2	10124-43-3	Carc. 1B; Muta. 2; Repr. 1B; Acute Tox. 4; Resp. Sens. 1; Skin Sens. 1	C Carcinogenic (article 57a) R Toxic for reproduction (article 57c)		Details
cobalt sulfide	215-273-3	1317-42-6	Skin Sens. 1			Details
Coccidioides inunitis	-	-			F Fungi	Details
colchicine	200-598-5	64-86-8	Muta. 1B; Acute Tox. 2			Details
colecalciferol; cholecalciferol; Vitamin D3	200-673-2	67-97-0	Acute Tox. 2; STOT RE 1			Details
Coltivirus	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
complex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated(n H2O,2 SUBSTANCE S171393	427-390-9	-	Skin Sens. 1			Details
condensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily; amino-ethyl-piperazine and triethylenetetramine) INDULIN MQK-1M	413-770-1	-	Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1			Details
constitutional isomers of penta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside; constitutional isomers of hexa-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside; constitutional isomers of hepta-O-allyl-β-D-fructofuransoyl-α-D-glucopyranoside ALLYL SUCROSE	419-640-0	68784-14-5	Acute Tox. 4			Details
copper chloride; copper (I) chloride; cuprous chloride	231-842-9	7758-89-6	Acute Tox. 4			Details
copper dihydroxide; copper(II) hydroxide	243-815-9	20427-59-2	Acute Tox. 2; Acute Tox. 4; Eye Dam. 1			Details
copper flakes (coated with aliphatic acid)	-	-	Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2			Details
copper sulphate	231-847-6	7758-98-7	Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2			Details
copper sulphate pentahydrate	616-477-9	7758-99-8	Acute Tox. 4; Eye Dam. 1			Details
copper(II) carbonate-copper(II) hydroxide (1:1)	235-113-6	12069-69-1	Acute Tox. 4; Eye Irrit. 2			Details
copper(II) methanesulfonate KUPFER-II-METHANSULFONAT; KUPFERMETHANSULFONAT	405-400-2	54253-62-2	Acute Tox. 4; Eye Dam. 1			Details
coriandrol; (S)-3,7-dimethyl-1,6-octadien-3-ol; d-linalool	204-810-7	126-90-9	Skin Sens. 1B			Details
Coronaviridae	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Corynebacterium diphtheriae	-	-			B Bacteria and similar species	Details
Corynebacterium minutissimum	-	-			B Bacteria and similar species	Details
Corynebacterium pseudotuberculosis	-	68583-16-4			B Bacteria and similar species	Details
Corynebacterium spp.	-	-			B Bacteria and similar species	Details
coumachlor (ISO); 3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin	201-378-1	81-82-3	STOT RE 2			Details
coumafuryl (ISO); fumarin; (RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin; 4-hydroxy-3-[3-oxo-1-(2-furyl)butyl]coumarin	204-195-5	117-52-2	Acute Tox. 3; STOT RE 1			Details
coumaphos (ISO); O-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate	200-285-3	56-72-4	Acute Tox. 2; Acute Tox. 4			Details
coumatetralyl; 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin	227-424-0	5836-29-3	Repr. 1B; Acute Tox. 2; Acute Tox. 3; STOT RE 1			Details
coumithoate (ISO); O,O-diethyl O-7,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate	-	572-48-5	Acute Tox. 3			Details
Cowpox virus	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Coxiella burnetii	-	-			B Bacteria and similar species	Details
Coxsackie viruses	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Creosote [The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.] The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.	232-287-5	8001-58-9	Carc. 1B			Details
Creosote oil [A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200 °C to 325 °C (392°F to 617°F).] A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200°C to 325°C (392°F to 617°F).	263-047-8	61789-28-4	Carc. 1B			Details
Creosote oil, acenaphthene fraction, acenaphthene-free; Wash Oil Redistillate [The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.] The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.	292-606-9	90640-85-0	Carc. 1B			Details
Creosote oil, acenaphthene fraction; Wash Oil [A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240 o C to 280 o C (464°F to 536 °F). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.] A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240°C to 280°C (464°F to 536°F). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.	292-605-3	90640-84-9	Carc. 1B			Details
Creosote oil, high-boiling distillate; Wash Oil [The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 °C (41°F).] The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5°C (41°F).	274-565-9	70321-79-8	Carc. 1B			Details
Creosote oil, low-boiling distillate; Wash Oil [The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 o C (100 oF).] The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38°C (100°F).	274-566-4	70321-80-1	Carc. 1B			Details
Creutzfeldt-Jakob disease	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
Crimean-Congo haemorrhagic fever	-	-			V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.	Details
crimidine (ISO);2-chloro-6-methylpyrimidin-4- yldimethylamine	208-622-6	535-89-7	Acute Tox. 2			Details
crotonaldehyde; 2-butenal	224-030-0	4170-30-3	Flam. Liq. 2; Muta. 2; Acute Tox. 2; Acute Tox. 3; STOT RE 2; STOT SE 3; Skin Irrit. 2; Eye Dam. 1			Details
crotoxyphos (ISO); 1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate	231-720-5	7700-17-6	Acute Tox. 3			Details
crufomate (ISO); 4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate	206-083-1	299-86-5	Acute Tox. 4			Details
Cryptococcus neoformans var. gattii	-	-			F Fungi	Details

Mostrati 1.801 - 1.850 su 4.917 risultati.

Export search results to:

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 26 aprile 2024. Database contains 4917 unique substances/entries.

Footer Nav Items